Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deuruxolitinib in adolescent severe alopecia areata
NCT07133308Phase 3Recruiting
- Start
- Aug 2025
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of deuruxolitinib in alopecia areata. Started Aug 2025; status: recruiting.
02
Drugs
deuruxolitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07133308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07133308.